SCHEMBL2358210

SCHEMBL2358210

O=C(O)N1CCC(COc2ccc3c(Cl)cccc3c2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 5/20 0.43
RBP4 P02753 2/20 0.39
TTR P02766 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
CHRNA7 P36544 1/20 0.38
FFAR1 O14842 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TNF P01375 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
NOD1 Q9Y239 1/20 0.38
MAOA P21397 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2355876 0.87 FFAR4 (0.42) RBP4TTRGRIN2DGRIN3BGRIN1
SCHEMBL2227841 0.85 SLC6A2 (0.52) RBP4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2227838 0.85 SLC6A2 (0.52) RBP4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2285047 0.85 SLC6A2 (0.52) RBP4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2227124 0.80 MMP2 (0.44) F2GRIN2BKDM4ETNFLMNA
SCHEMBL2229023 0.80 MMP2 (0.45) F2GRIN2BKDM4ETNFLMNA
SCHEMBL2790672 0.79 FAAH (0.46) F2FFAR1
SCHEMBL2793669 0.79 FAAH (0.46) F2FFAR1
SCHEMBL20744482 0.78 CHRNB4 (0.52) F2RBP4GRIN2DGRIN3BGRIN1
SCHEMBL20744463 0.78 CHRNB4 (0.52) F2RBP4GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011089550-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2011-07-28 WO disclosed